An open-label, non-comparative, non-interventional, multi-center, post-authorization safety study on the administration of rabeprazole to adults with gastro-esophageal reflux disease

Annals of Gastroenterology

Volumn 27, Issue 2, 2014, Pages 133-138

  Zouboulis Vafiadis, Irini ^a   Paraskevas, Emmanuel ^b   Tzourmakliotis, Dimitrios ^c   Hatzikyriakou, Maria ^d   Mestoussi, Angeliki ^d   Vasdekis, Vassilios ^e   Katsilabros, Nikolaos ^a   Arhimandritis, Athanasios ^a   Papadokostopouloud, Alexandra ^d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Agios Savvas Cancer Hospital   (Greece)

^c Gastroenterology Department   (Greece)

^d Janssen Cilag Pharmaceutical SACI   (Greece)

^e ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS   (Greece)

Author keywords

Gastro esophageal reflux disease; Post authorization safety study; Rabeprazole; Real life clinical practice

Indexed keywords

RABEPRAZOLE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COUGHING; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DUODENUM ULCER; ESOPHAGITIS; FEMALE; FLATULENCE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; RECURRENT DISEASE; REMISSION; SOMNOLENCE; STOMACH ULCER; SYMPTOMATOLOGY; TINNITUS; UPPER ABDOMINAL PAIN; VERY ELDERLY; XEROSTOMIA;

EID: 84897076545     PISSN: 11087471     EISSN: 17927463     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Baldwin CM, Keam SJ. Rabeprazole: a review of its use in the management of gastric acid-related diseases in adults. Drugs 2009;69:1373-1401.
2. Dadabhai A, Friedenberg FK. Rabeprazole: a pharmacologic and clinical review for acid-related disorders. Expert Opin Drug Saf 2009;8:119-126.
3. Pariet™ summary of product characteritstics. Available at http:// www.medicines.ie/medicine/2103/SPC/Pariet/. Accessed 16 September 2010.
4. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85-92.
5. Veldhuyzen van Zanten SJ, Tytgat KM, Pollak PT, et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? J Clin Epidemiol 1993;46:273-279.
6. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. Oxford: Blackwell Scientific Publications; 2002.
7. Bishop YMM, Fienberg SE, Holland PW. Discrete multivariate analysis, theory and practice. Cambridge, Massachusetts: MIT Press; 1995.
8. Robinson M, Fitzgerald S, Hegedus R, Murthy A, Jokubaitis L; FAST Trial Investigators. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther 2002;16:445-454.